Microfluidics startup Arradial of Bedford, Mass., has appointed Mark Tepper as president and CEO, and John Havens as senior vice president of technology. Tepper comes to Arradial after serving as vice president of research and operations at the Serono Pharmaceutical Research Institute, where he was a member of the senior research management team and headed the company’s lead discovery efforts. Prior to holding this position, Tepper served in leadership positions at the Bristol-Myers Squibb Pharmaceutical Research Institute and the University of Massachusetts Medical School. Tepper holds a PhD in biochemistry and biophysics from Columbia University.
Havens comes to Arradial from Nanogen, where he served as senior director of chemistry and high-throughput screening, and developed SNP genotyping and SNP discovery efforts. He has two patents issued for Nanogen in the SNP platform area. He also supervised biomolecular attachment chemistry development on the company’s NanoChip platform, and led development of electronic kinase HTS assays and substrate-identification technologies. Havens is moving to Arradial, he said, because he specializes in startup companies.